Diabetes Mellitus, Type 1
"Diabetes Mellitus, Type 1" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence.
| Descriptor ID |
D003922
|
| MeSH Number(s) |
C18.452.394.750.124 C19.246.267 C20.111.327
|
| Concept/Terms |
Diabetes Mellitus, Type 1- Diabetes Mellitus, Type 1
- Diabetes Mellitus, Brittle
- Brittle Diabetes Mellitus
- Diabetes Mellitus, Insulin-Dependent
- Diabetes Mellitus, Insulin Dependent
- Insulin-Dependent Diabetes Mellitus
- Diabetes Mellitus, Juvenile-Onset
- Diabetes Mellitus, Juvenile Onset
- Juvenile-Onset Diabetes Mellitus
- Diabetes Mellitus, Ketosis-Prone
- Diabetes Mellitus, Ketosis Prone
- Ketosis-Prone Diabetes Mellitus
- Juvenile-Onset Diabetes
- Diabetes, Juvenile-Onset
- Juvenile Onset Diabetes
- Diabetes Mellitus, Type I
- Diabetes Mellitus, Sudden-Onset
- Diabetes Mellitus, Sudden Onset
- Mellitus, Sudden-Onset Diabetes
- Sudden-Onset Diabetes Mellitus
- Type 1 Diabetes Mellitus
- Diabetes Mellitus, Insulin-Dependent, 1
- Insulin-Dependent Diabetes Mellitus 1
- Insulin Dependent Diabetes Mellitus 1
- Type 1 Diabetes
- Diabetes, Type 1
- IDDM
|
Below are MeSH descriptors whose meaning is more general than "Diabetes Mellitus, Type 1".
Below are MeSH descriptors whose meaning is more specific than "Diabetes Mellitus, Type 1".
This graph shows the total number of publications written about "Diabetes Mellitus, Type 1" by people in this website by year, and whether "Diabetes Mellitus, Type 1" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 3 | 0 | 3 |
| 1995 | 6 | 3 | 9 |
| 1996 | 4 | 2 | 6 |
| 1997 | 10 | 1 | 11 |
| 1998 | 4 | 2 | 6 |
| 1999 | 6 | 2 | 8 |
| 2000 | 5 | 3 | 8 |
| 2001 | 7 | 3 | 10 |
| 2002 | 4 | 0 | 4 |
| 2003 | 6 | 4 | 10 |
| 2004 | 5 | 2 | 7 |
| 2005 | 4 | 1 | 5 |
| 2006 | 6 | 3 | 9 |
| 2007 | 13 | 2 | 15 |
| 2008 | 9 | 5 | 14 |
| 2009 | 10 | 2 | 12 |
| 2010 | 11 | 4 | 15 |
| 2011 | 12 | 5 | 17 |
| 2012 | 15 | 2 | 17 |
| 2013 | 14 | 4 | 18 |
| 2014 | 23 | 2 | 25 |
| 2015 | 16 | 2 | 18 |
| 2016 | 9 | 3 | 12 |
| 2017 | 11 | 1 | 12 |
| 2018 | 19 | 5 | 24 |
| 2019 | 16 | 3 | 19 |
| 2020 | 20 | 3 | 23 |
| 2021 | 16 | 2 | 18 |
| 2022 | 13 | 0 | 13 |
| 2023 | 11 | 1 | 12 |
| 2024 | 7 | 2 | 9 |
To return to the timeline,
click here.
Below are the most recent publications written about "Diabetes Mellitus, Type 1" by people in Profiles.
-
The Impact of Unrelated Future Medical Costs on Economic Evaluation Outcomes for Different Models of Diabetes. Appl Health Econ Health Policy. 2024 Nov; 22(6):861-869.
-
The moderating role of diabetes distress on the effect of a randomized eHealth intervention on glycemic control in Black adolescents with type 1 diabetes. J Pediatr Psychol. 2024 Aug 01; 49(8):538-546.
-
Start codon variant in LAG3 is associated with decreased LAG-3 expression and increased risk of autoimmune thyroid disease. Nat Commun. 2024 Jul 09; 15(1):5748.
-
Inhibition of the eukaryotic initiation factor-2a kinase PERK decreases risk of autoimmune diabetes in mice. J Clin Invest. 2024 Jun 18; 134(16).
-
Diabetes distress in urban Black youth with type 1 diabetes and their caregivers: associations with glycemic control, depression, and health behaviors. J Pediatr Psychol. 2024 Jun 13; 49(6):394-404.
-
The role of genetic risk factors, diet, and gut microbiota in type 1 diabetes mellitus, pancreas and pancreatic islet transplantation. Endokrynol Pol. 2024; 75(2):140-147.
-
Diffusion and Disparities: Rural Uptake of Continuous Glucose Monitors. Diabetes Care. 2024 Mar 01; 47(3):344-345.
-
Longitudinal Assessment of Pancreas Volume by MRI Predicts Progression to Stage 3 Type 1 Diabetes. Diabetes Care. 2024 Mar 01; 47(3):393-400.
-
Rilparencel (Renal Autologous Cell Therapy-REACT®) for Chronic Kidney Disease and Type 1 and Type 2 Diabetes: Phase 2 Trial Design Evaluating Bilateral Kidney Dosing and Redosing Triggers. Am J Nephrol. 2024; 55(3):389-398.
-
Discordant Effects of Polyamine Depletion by DENSpm and DFMO on ß-cell Cytokine Stress and Diabetes Outcomes in Mice. Endocrinology. 2024 Jan 16; 165(3).